+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Protection against experimental Salmonella typhimurium infection in mice. Immunostimulating activity of heterologous Salmonella S-forms, R-mutants, lipopolysaccharides and muramyl dipeptide in vaccines combined with S. typhimurium



Protection against experimental Salmonella typhimurium infection in mice. Immunostimulating activity of heterologous Salmonella S-forms, R-mutants, lipopolysaccharides and muramyl dipeptide in vaccines combined with S. typhimurium



Zentralblatt für Bakteriologie Mikrobiologie und Hygiene. Series A Medical Microbiology Infectious Diseases Virology Parasitology 257(3): 414-425



In vaccines consisting of acetone-killed Salmonella, 90% of the bacteria were replaced by: heterologous Salmonella S-forms, R-mutants of Salmonella or Escherichia coli, lipopolysaccharide from S. typhimurium (S-form) or from R-mutants of Salmonella or E. coli and by muramyl dipeptide. Active immunizations of NMRI mice with these vaccines were undertaken. Mice received two intraperitoneal injections of the vaccines at intervals of 14 days, and were challenged with various doses of S. typhimurium C5 10 days later. The protective capacity of the mixed vaccines was compared with that of monovaccines (S. typhimurium) and with the effectiveness of vaccines consisting of the supplementing component (relatively weak immunizing ability) alone. The LD50 served as criterion for protective capacity. The results showed that S. typhimurium S-form could be replaced by Salmonella R-mutants belonging to different chemotypes without a recognizable decrease in protective immunizing capacity of the vaccines. Effective vaccines were also attained when heterologous Salmonella S-forms, which exhibit no O-antigenic determinants in common with S. typhimurium, were used as supplements. Mixtures with E. coli R-mutants proved to be less effective. In addition, the diminished dose of S. typhimurium could be so effectively supplemented with lipopolysaccharide from S. minnesota R 595 that complete protection was achieved. In contrast, comparable doses of R lipopolysaccharides from E. coli were somewhat less effective. Vaccines of LPS-extracted bacteria exhibited a reduced protective capacity and were ineffective when used as supplements in mixed vaccines. Analogous results were obtained when R-mutants served as basic vaccines in place of the S. typhimurium S-form indicating that an immunogenic component is enhanced in these organisms too and that their immunogenic capacity is not brought about barely by general stimulation of the immune system. However, the full effectiveness of the R-monovaccines was often not attained with supplements. Immunization with mixed vaccines of S. typhimurium S-form and heterologous Salmonella S-forms or Salmonella R-mutants led to equally high agglutinin and haemagglutinin titers as those obtained with monovaccines of S. typhimurium S-form.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 044074611

Download citation: RISBibTeXText

PMID: 6385567


Related references

Protection against salmonella typhimurium infection in mice immunoenhancing activity of heterologous salmonella s forms r mutants lipopolysaccharides and muramyl dipeptide used in combination with salmonella typhimurium as mixed vaccines. Zentralblatt fuer Bakteriologie Mikrobiologie und Hygiene Series A 257(3): 414-425, 1984

Proteins from salmonella R-mutants mediating protection against Salmonella typhimurium infection in mice Iii. Separation and purification of soluble proteins and their use as vaccines and as precipitating antigens. Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene. Series A: Medical Microbiology, Infectious Diseases, Virology, Parasitology 260(4): 448-458, 1985

Proteins from salmonella r mutants mediating protection against salmonella typhimurium infection in mice iii. separation and purification of soluble proteins and their use as vaccines and as precipitating antigens. Zentralblatt fuer Bakteriologie Mikrobiologie und Hygiene Series A 260(4): 448-458, 1985

Protection against salmonella typhimurium, salmonella gallinarum, and salmonella enteritidis infection in layer chickens conferred by a live attenuated salmonella typhimurium strain. Immune Network 15(1): 27-36, 2015

A hema mutation renders salmonella typhimurium avirulent in mice yet capable of eliciting protection against intravenous infection with salmonella typhimurium. Microbial Pathogenesis 11(4): 289-296, 1991

Salmonella Typhimurium TTSS-2 deficient mig-14 mutant shows attenuation in immunocompromised mice and offers protection against wild-type Salmonella Typhimurium infection. Bmc Microbiology 13: 236, 2013

The protein lipo poly saccharide complex extracted with tri chloro acetic acid from salmonella typhimurium effective in protection of mice against salmonella typhimurium infection. Parasite Immunology 4(4): 259-272, 1982

Enhancement of protection against salmonella infection in mice mediated by a synthetic lipopeptide analogue of bacterial lipoprotein in salmonella typhimurium vaccines. Zentralblatt fuer Bakteriologie 271(4): 493-500, 1989

Immunization against salmonella typhimurium infection in mice. Chemical composition and protecting activity of different extracts from salmonella R mutants. Zentralblatt für Bakteriologie. 1. Abt. Originale. A: Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie 248(1): 64-80, 1980

Proteins from salmonella r mutants mediating protection against salmonella typhimurium infection in mice 2. protection tests performed with proteins free from lipopolysaccharide. Zentralblatt fuer Bakteriologie Mikrobiologie und Hygiene Series A 259(3): 367-377, 1985

Proteins from salmonella r-mutants mediating protection against salmonella typhimurium infection in mice Ii. Protection tests performed with proteins free from lipopolysaccharide. Zentralblatt für Bakteriologie, Mikrobiologie und Hygiene. Series A: Medical Microbiology, Infectious Diseases, Virology, Parasitology 259(3): 367-377, 1985

Proteins from salmonella r mutants mediating protection against salmonella typhimurium infection in mice 1. preparation of proteins free from lipo poly saccharide using various chromatographic methods. Zentralblatt fuer Bakteriologie Mikrobiologie und Hygiene 1 Abt Originale A 253(1): 88-101, 1982

Pathogenicity of Salmonella typhimurium administered subcutaneously to mice in mixture with each polynucleotide complex from Salmonella typhimurium, Salmonella typhosa, and Salmonella newport. American Journal of Veterinary Research 12(45): 340-344, 1951

Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice. Infection and Immunity 83(12): 4504-4512, 2015

Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium. Infection and Immunity 25(3): 863-872, 1979